Multiple PPI dosage form
Details for Australian Patent Application No. 2005264864 (hide)
International Classifications
Event Publications
18 January 2007 PCT application entered the National Phase
PCT publication WO2006/009602 Priority application(s): WO2006/009602
25 November 2010 Alteration of Name
The name of the applicant has been altered to Takeda Pharmaceuticals North America, Inc.
11 August 2011 Application Accepted
Published as AU-B-2005264864
8 December 2011 Standard Patent Sealed
26 July 2012 Application for Amendment
The nature of the amendment is: Amend the patentee name from Takeda Pharmaceuticals North America, Inc. to Takeda Pharmaceuticals U.S.A., Inc. . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser